IMPN Implenia AG

Implenia wins further large, complex new-build and modernisation projects in Switzerland

Implenia AG / Key word(s): Incoming Orders
Implenia wins further large, complex new-build and modernisation projects in Switzerland

16.11.2022 / 07:00 CET/CEST


Office and commercial property in Lucerne | New building for Lucerne Cantonal Hospital | Several modernisation projects in German and French-speaking regions of Switzerland | Contracts with total amount of almost CHF 150 million

Glattpark (Opfikon), 16 November 2022 – Implenia’s Division Buildings has received an order from SBB Immobilien to build an office and commercial building on the Rösslimatt site close to Lucerne railway station. The company is also building a new children’s hospital/women’s clinic for Lucerne Cantonal Hospital (LUKS). In addition, Implenia has won four new modernisation projects in the German and French-speaking parts of Switzerland; modernisation work is becoming increasingly important for Division Buildings.  

Rösslimatt, Lucerne – office and commercial property
As part of the development of the Rösslimatt neighbourhood in Lucerne, Implenia is building an office and commercial property for SBB Immobilien just next to Lucerne railway station, with space for around 1,000 employees as well as a wide range of retail and restaurant outlets on the ground floor. Implenia has been commissioned as total contractor to carry out the basic construction. The Rösslimatt site is being developed sustainably and to high quality standards: as well as certification as a 2000-Watt site, the building will be built to the DGNB silver standard. The project, worth over CHF 50 million, started in September 2022 and will take a good two years to complete. The Lean Construction method is being used for the execution phase.

Lucerne Cantonal Hospital – new children’s hospital/women’s clinic 
Implenia has been awarded the contract to build the new children’s hospital/women’s clinic at Lucerne Cantonal Hospital (LUKS). Health sector construction projects are a strategic focus for Implenia’s Division Buildings. Work on the project, worth CHF 40.8 million, began in August 2022 and will continue until mid-2024. The new building will facilitate the further development of paediatric medicine (paediatrics and paediatric surgery), as well as of obstetrics and gynaecology at the highest level. It marks an important step forward for healthcare provision in Central Switzerland as a whole. 
The building will be operated sustainably thanks to the Minergie-P-ECO building standard, a power grid based on an energy bank under the new building (270 geothermal probes) and a large-scale photovoltaic system on the roof. The project is being planned and executed with BIM (Building Information Modelling).

Modernisation projects in the German and French-speaking parts of Switzerland – energy-efficient renovation and conversion becoming increasingly important 
Switzerland has a high proportion of old properties, some of which have protected status. They have to be adapted to modern requirements and updated to be more energy-efficient. Jens Vollmar, Head Division Buildings at Implenia: “The preservation and protection of buildings is a high priority in Switzerland. However, these buildings still have to be used and operated economically and sustainably. With its strong focus on sustainability, Implenia brings long experience and comprehensive skills to the job of renovating existing buildings in accordance with customer requirements.”

Implenia has recently won four large, complex modernisation projects in the German and French-speaking parts of Switzerland. It has been asked to renovate the listed Draisine Hall (formerly the Swiss Locomotive and Machinery Factory), including kindergarten and primary school, at the Lokstadt site in Winterthur. The project, commissioned by owner Ina Invest, includes master builder work and wooden construction. On Dornacherstrasse in Basel, Division Buildings is renovating an occupied residential apartment building on behalf of a large Swiss bank. In Cugy (Canton Vaud) Implenia has been commissioned by the same bank to undertake comprehensive renovation of a large development in line with Minergie standards. Implenia is also modernising three occupied residential apartment buildings on Rue de Beaumont in Geneva on behalf of two real estate companies. These four modernisation contracts are worth over CHF 55 million in total.

Rösslimatt: Office and commercial property in a prime location by Lucerne 
train station (image: © SBB Immobilien).

Contact for media:
Corporate Communications, T 7,  

 

Contact for Investors and Analysts:
Investor Relations, T 4,  

Dates for investors: 
1 March 2023: Annual results 2022, Analysts and Media Conference 
28 March 2023: Annual General Meeting

As Switzerland’s leading construction and real estate service provider, Implenia develops and builds homes, workplaces and infrastructure for future generations in Switzerland and Germany. It also offers tunnelling and related infrastructure projects in further markets. Formed in 2006, the company can look back on around 150 years of construction tradition. The company brings together the know-how of its highly skilled development, planning and execution units under the umbrella of an integrated leading multinational construction and real estate service provider. With its broad offering and the expertise of its specialists, the Group realises large, complex projects and provides client-centric support across the entire life cycle of a building or structure. It focuses on client needs and on striking a sustainable balance between commercial success and social and environmental responsibility. Implenia, with its headquarters in Opfikon near Zurich, employs more than 7,700 people across Europe and posted revenue of CHF 3.8 billion in 2021. The company is listed on the SIX Swiss Exchange (IMPN, CH0023868554). More information can be found at .



End of Media Release


Language: English
Company: Implenia AG
Industriestrasse 24
8305 Dietlikon
Switzerland
Phone: 4
E-mail:
Internet:
ISIN: CH0023868554
Valor: A0JEGJ
Listed: SIX Swiss Exchange
EQS News ID: 1488787

 
End of News EQS News Service

1488787  16.11.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1488787&application_name=news&site_id=research_pool
EN
16/11/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Implenia AG

Implenia AG: 1 director

A director at Implenia AG sold 1,607 shares at 65.315CHF and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Bruno Cavalier ... (+3)
  • Bruno Cavalier
  • Oliver Metzger
  • Sinan Doganli
Bruno Cavalier ... (+3)
  • Bruno Cavalier
  • Oliver Metzger
  • Sinan Doganli
CON CONTINENTAL AKTIENGESELLSCHAFT
NDX1 NORDEX SE
FME FRESENIUS MEDICAL CARE AG
FRA FRAPORT AG
TKA THYSSENKRUPP AG
WCH WACKER CHEMIE AG
G1A GEA GROUP AG
MC LVMH MOET HENNESSY LOUIS VUITTON SE
MTX MTU AERO ENGINES AG
CBK COMMERZBANK AG
HO THALES SA
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
EVT EVOTEC SE
HNR1 HANNOVER RUECK SE
GBF BILFINGER SE
AFX CARL ZEISS MEDITEC AG
SRT3 SARTORIUS AG PREF
GLJ GRENKE AG
UTDI UNITED INTERNET AG
LXS LANXESS AG
GXI GERRESHEIMER AG
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
VNA VONOVIA SE
ELG ELMOS SEMICONDUCTOR SE
BOSS HUGO BOSS AG
SDF K+S AG
ZAL ZALANDO SE
BAS BASF SE
FRE FRESENIUS SE & CO. KGAA
BAYN BAYER AG
HEN3 HENKEL AG & CO. KGAA PREF
01913 PRADA S.P.A.
IMPN IMPLENIA AG
DEZ DEUTZ AG
INH INDUS HOLDING AG
AIXA AIXTRON SE
KRN KRONES AG
WIE WIENERBERGER AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
BC8 BECHTLE AG
ADN1 ADESSO AG
EVK EVONIK INDUSTRIES AG
KGX KION GROUP AG
MONC MONCLER SPA
WAF SILTRONIC AG
SMHN SUESS MICROTEC AG
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
NN NN GROUP N.V.
HBH HORNBACH HOLDING AG & CO. KGAA
FNTN FREENET AG
JUN3 JUNGHEINRICH AG PREF
BFSA BEFESA SA
JST JOST WERKE AG
DMP DERMAPHARM HOLDING SE
VOS VOSSLOH AG
SANT S&T AG
JEN JENOPTIK AG
AEIN ALLGEIER HOLDING AG
KBX KNORR-BREMSE AG
HAG HENSOLDT AG
SFQ SAF-HOLLAND SE
NA9 NAGARRO
FPE3 FUCHS PETROLUB SE
SPAC 468 SPAC I SE
STM STABILUS SE
IOS IONOS GROUP SE
TUI TUI AG
SCHOTT PHARMA AG
CVC CVC CAPITAL PARTNERS PLC
Bruno Cavalier ... (+3)
  • Bruno Cavalier
  • Oliver Metzger
  • Sinan Doganli
Bruno Cavalier ... (+3)
  • Bruno Cavalier
  • Oliver Metzger
  • Sinan Doganli
CON CONTINENTAL AKTIENGESELLSCHAFT
NDX1 NORDEX SE
FME FRESENIUS MEDICAL CARE AG
FRA FRAPORT AG
TKA THYSSENKRUPP AG
WCH WACKER CHEMIE AG
G1A GEA GROUP AG
MC LVMH MOET HENNESSY LOUIS VUITTON SE
MTX MTU AERO ENGINES AG
CBK COMMERZBANK AG
HO THALES SA
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
EVT EVOTEC SE
HNR1 HANNOVER RUECK SE
GBF BILFINGER SE
AFX CARL ZEISS MEDITEC AG
SRT3 SARTORIUS AG PREF
GLJ GRENKE AG
UTDI UNITED INTERNET AG
LXS LANXESS AG
GXI GERRESHEIMER AG
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
VNA VONOVIA SE
ELG ELMOS SEMICONDUCTOR SE
BOSS HUGO BOSS AG
SDF K+S AG
ZAL ZALANDO SE
BAS BASF SE
FRE FRESENIUS SE & CO. KGAA
BAYN BAYER AG
HEN3 HENKEL AG & CO. KGAA PREF
01913 PRADA S.P.A.
IMPN IMPLENIA AG
DEZ DEUTZ AG
INH INDUS HOLDING AG
AIXA AIXTRON SE
KRN KRONES AG
WIE WIENERBERGER AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
BC8 BECHTLE AG
ADN1 ADESSO AG
EVK EVONIK INDUSTRIES AG
KGX KION GROUP AG
MONC MONCLER SPA
WAF SILTRONIC AG
SMHN SUESS MICROTEC AG
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
NN NN GROUP N.V.
HBH HORNBACH HOLDING AG & CO. KGAA
FNTN FREENET AG
JUN3 JUNGHEINRICH AG PREF
BFSA BEFESA SA
JST JOST WERKE AG
DMP DERMAPHARM HOLDING SE
VOS VOSSLOH AG
SANT S&T AG
JEN JENOPTIK AG
AEIN ALLGEIER HOLDING AG
KBX KNORR-BREMSE AG
HAG HENSOLDT AG
SFQ SAF-HOLLAND SE
NA9 NAGARRO
FPE3 FUCHS PETROLUB SE
SPAC 468 SPAC I SE
STM STABILUS SE
IOS IONOS GROUP SE
TUI TUI AG
SCHOTT PHARMA AG
CVC CVC CAPITAL PARTNERS PLC

ResearchPool Subscriptions

Get the most out of your insights

Get in touch